Eh, logic also suggested a PFS benefit in the liver would of translated into OS. Face value assumptions in the med space is dangerous business.
That will have to be determined by a new round of clinical trials!
wats going on ???, page-31
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
0.005(2.86%) |
Mkt cap ! $76.40M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.0¢ | 17.5¢ | $2.096K | 11.86K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 7403700 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 1231722 | 29 |
View Market Depth
| Last trade - 15.33pm 03/09/2024 (20 minute delay) ? |
| SRX (ASX) Chart |